Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finn

Showing results (171-180 of 407) with videos related to

Pageof 41
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2005
Activation of mitogen activated protein kinase pathways and melanogenesis by novel nitro-derivatives of 7-hydroxycomarin in human malignant melanoma cellsGregory J Finn, Bernadette S Creaven, Denise A Egan
Archives of Dermatology|September 17, 2008
Cutaneous complication of chronic fatigue: an answer from the horse's mouthAlexander J Finn, Matthew K Flynn, Wain L White
The Journal of Organic Chemistry|April 23, 2005
Reactions of indole derivatives with oxiranes and aziridines on silica. Synthesis of beta-carbolin-1-one mimic of pancratistatinTomas Hudlicky, Uwe Rinner, Kevin J Finn, et al.
Science (New York, N.Y.)|August 21, 2010
Loss of DNA replication control is a potent inducer of gene amplificationBrian M Green, Kenneth J Finn, Joachim J Li
Cancer Immunology, Immunotherapy : CII|September 4, 2012
Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoformsLixin Zhang, Anda Vlad, Christine Milcarek, et al.
Journal of the American Chemical Society|December 20, 2011
Convergent, enantiospecific total synthesis of the hypocholesterolemic agent (+)-compactinP A Grieco, R Lis, R E Zelle, et al.
Protein Expression and Purification|June 5, 2001
Recombinant human tumor antigen MUC1 expressed in insect cells: structure and immunogenicityM Soares, F G Hanisch, O J Finn, et al.
Frontiers in Immunology|June 10, 2022
Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and VaccinesNicolas Çuburu, Olivera J Finn, Sjoerd H Van Der Burg
Human Immunology|June 1, 1989
A human suppressor T-cell factor that inhibits T-cell replication by interaction with the IgM-Fc receptor (CD7)M Emara, W M Baldwin, O J Finn, et al.
Health Care Financing Review|March 3, 1997
Personal decisionmaking styles and long-term care choicesS K Maloney, J Finn, D L Bloom, et al.
Pageof 41

Showing results (171-180 of 407) with videos related to

Sort By:
Pageof 41
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2005
Activation of mitogen activated protein kinase pathways and melanogenesis by novel nitro-derivatives of 7-hydroxycomarin in human malignant melanoma cellsGregory J Finn, Bernadette S Creaven, Denise A Egan
Archives of Dermatology|September 17, 2008
Cutaneous complication of chronic fatigue: an answer from the horse's mouthAlexander J Finn, Matthew K Flynn, Wain L White
The Journal of Organic Chemistry|April 23, 2005
Reactions of indole derivatives with oxiranes and aziridines on silica. Synthesis of beta-carbolin-1-one mimic of pancratistatinTomas Hudlicky, Uwe Rinner, Kevin J Finn, et al.
Science (New York, N.Y.)|August 21, 2010
Loss of DNA replication control is a potent inducer of gene amplificationBrian M Green, Kenneth J Finn, Joachim J Li
Cancer Immunology, Immunotherapy : CII|September 4, 2012
Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoformsLixin Zhang, Anda Vlad, Christine Milcarek, et al.
Journal of the American Chemical Society|December 20, 2011
Convergent, enantiospecific total synthesis of the hypocholesterolemic agent (+)-compactinP A Grieco, R Lis, R E Zelle, et al.
Protein Expression and Purification|June 5, 2001
Recombinant human tumor antigen MUC1 expressed in insect cells: structure and immunogenicityM Soares, F G Hanisch, O J Finn, et al.
Frontiers in Immunology|June 10, 2022
Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and VaccinesNicolas Çuburu, Olivera J Finn, Sjoerd H Van Der Burg
Human Immunology|June 1, 1989
A human suppressor T-cell factor that inhibits T-cell replication by interaction with the IgM-Fc receptor (CD7)M Emara, W M Baldwin, O J Finn, et al.
Health Care Financing Review|March 3, 1997
Personal decisionmaking styles and long-term care choicesS K Maloney, J Finn, D L Bloom, et al.
Pageof 41